Concepedia

Publication | Open Access

Inhibition of MDM2 Re-Sensitizes Rapamycin Resistant Renal Cancer Cells via the Activation of p53

15

Citations

15

References

2016

Year

Abstract

Our study reports a novel mechanism for rapamycin resistance in human renal cancer and provides a new perspective for the development of anti-cancer drugs.

References

YearCitations

Page 1